Alnylam Pharmaceuticals Inc (ALNY) — Cash Flow Quality Index
Alnylam Pharmaceuticals Inc (ALNY) has a Cash Flow Quality Index of 0.88x as of December 2025. Operating cash flow of $163.56 Million is below net income of $186.42 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ALNY long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Alnylam Pharmaceuticals Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Alnylam Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Alnylam Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Alnylam Pharmaceuticals Inc (2025–2025)
Year-by-year earnings quality comparison for Alnylam Pharmaceuticals Inc. For live market cap and the full company financial profile, see ALNY company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.67x | $524.08 Million | $313.75 Million | — |